SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-045954
Filing Date
2013-09-27
Accepted
2013-09-27 16:49:03
Documents
1
Period of Report
2013-09-25

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c601713_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c601713_4x0.xml 4 6702
  Complete submission text file 0001209191-13-045954.txt   8389
Mailing Address 325 VASSAR STREET CAMBRIDGE MA 02139
Business Address 325 VASSAR STREET CAMBRIDGE MA 02139 6174913400
BIND Therapeutics, Inc (Issuer) CIK: 0001385228 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10A 60-LETIYA OKTYABRYA PROSPECT MOSCOW 1Z 117036
Business Address 10A 60-LETIYA OKTYABRYA PROSPECT MOSCOW 1Z 117036 495-988-5388
RUSNANO (Reporting) CIK: 0001548606 (see all company filings)

State of Incorp.: 1Z
Type: 4 | Act: 34 | File No.: 001-36072 | Film No.: 131120417